Microphthalmia family of transcription factors associated renal cell carcinoma

Ling Xie1,2, Yifen Zhang1, Chin-Lee Wu2

  • 1Department of Pathology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Asian Journal of Urology
|November 27, 2019
PubMed

Insights

This review details rare kidney cancer subtypes, focusing on MiT family translocation renal cell carcinoma (tRCC) involving TFE3 and TFEB gene rearrangements. Understanding these rare renal neoplasms aids clinical management.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • The microphthalmia (MiT) transcription factor family includes TFE3, TFEB, TFEC, and MITF.
  • MiT family translocation renal cell carcinoma (tRCC), including Xp11 and t(6;11) subtypes, was newly defined in the 2016 WHO classification.
  • These RCC subtypes are characterized by specific gene rearrangements involving TFE3 or TFEB.

Purpose of the Study:

  • To review and analyze newly described MiT family-associated renal neoplasms.
  • To consolidate clinicopathological, immunohistochemical, and molecular/genetic data for these rare RCC subtypes.
  • To enhance understanding and inform clinical management strategies for these rare renal tumors.

Main Methods:

  • Literature review of available studies on MiT family-associated renal neoplasms.
  • Analysis of clinicopathological and immunohistochemical features.
  • Summary of molecular and genetic evidence, including gene fusions and amplifications.

Main Results:

  • Identification of distinct clinicopathological and immunohistochemical features dependent on fusion partners in TFE3-rearranged RCC.
  • Recognition of TFEB-amplified RCC and melanotic MiT family translocation neoplasms as unique subtypes.
  • Association of MITF with a distinct category of renal neoplasms.

Conclusions:

  • MiT family transcription factors play a crucial role in the pathogenesis of specific renal cell carcinoma subtypes.
  • Detailed characterization of these rare RCCs is essential for accurate diagnosis and treatment.
  • This review provides a comprehensive overview to support clinical decision-making for patients with MiT family-associated renal neoplasms.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.6K